Tom Larson

Managing Director, Life Sciences & Healthcare at Acadia Leadership Partners INC
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Jeff Hoover

Any organization would be fortunate to have Tom Larson's leadership and talents. Tom was my counterpart as a Region Director in Chicago, and we collaborated on business planning, people development & talent career paths, and shared key strategic approaches to our respective businesses. Tom served as a fantastic partner to me, exhibiting the utmost character traits combined with high moral and ethical behaviors. Tom has a great business acumen that has a foundation in a passion for people. Tom finds the delicate balance between motivation and accountability and always gets the most out of his team. He takes a very strategic approach to his business, and has instituted those strategies flawlessly in the hospital setting that resulted in a President's Circle performance his first year on the job. Tom has a deep understanding of his products and markets and does an outstanding job of connecting with customers and mentoring his team to develop similar traits. In closing, Tom's experience and knowledge prepares him to have immediate impact on a new business.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Business Consulting and Services
    • 1 - 100 Employee
    • Managing Director, Life Sciences & Healthcare
      • Feb 2021 - Present

      Acadia Leadership Partners (ALPS) is an innovation, technology, and professional services company with a suite of advanced cybersecurity solutions, intelligent automation, robotics processing automation, compliance, and data-driven solutions. At ALPS, critical thinking is our service. Acadia Leadership Partners (ALPS) is an innovation, technology, and professional services company with a suite of advanced cybersecurity solutions, intelligent automation, robotics processing automation, compliance, and data-driven solutions. At ALPS, critical thinking is our service.

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Commercial Advisor
      • Jan 2021 - Feb 2023

      InnaMed is a startup aiming to enhance the patient experience with at-home blood testing using a microsample collection technology and a cloud-based health analytics data transmission platform. Commercial Advisor Advisor to the innovative leadership team on commercial strategy and leading their partnership discussions with pharmaceutical companies and CROs. InnaMed is a startup aiming to enhance the patient experience with at-home blood testing using a microsample collection technology and a cloud-based health analytics data transmission platform. Commercial Advisor Advisor to the innovative leadership team on commercial strategy and leading their partnership discussions with pharmaceutical companies and CROs.

  • Ascendis Pharma A/S
    • Palo Alto, California
    • SVP & Chief Commercial Officer at ASCENDIS PHARMA
      • Apr 2018 - Aug 2020

      Ascendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients’ lives. SVP & Chief Commercial Officer at ASCENDIS PHARMA Global responsibility for transitioning the company from pre-commercial to first commercial launch. Expanded leadership responsibilities include inheriting the Medical Affairs Organization. Quickly diagnosed and resolved organizational issues, reorganized and focused the team to deliver on launch priorities. Show less

    • VP & Chief Commercial Officer
      • Mar 2016 - Mar 2018

      MT Pharma America, Inc.is a subsidiary of Mitsubishi Tanabe Pharma Holdings America, Inc., subsidiary of Mitsubishi Tanabe Pharma Corporation, headquartered in Chuo-ku, Osaka, Japan Chief Commercial Officer Built/designed/hired the US commercial organization and successfully transitioned the company from pre-commercial to launching the first commercial product in the US, an IV infusion orphan drug for the treatment of ALS, also known as Lou Gehrig’s disease. Exceeded launch stretch goal forecast. Direct reports included marketing, market access, commercial analytics, commercial operations, corporate communications, patient advocacy and sales. Show less

    • Vice President of Marketing, Sales and Commercial Operations
      • Sep 2013 - Mar 2016

      Private equity backed start-up Biopharmaceutical Company specializing in rare diseases and orphan drugs. First commercial leader recruited to build and hire the commercial infrastructure, lead commercial business operations and to evaluate business development opportunities (recruited by CEO and CBO). • Shaped the strategic focus and direction of the company. • Commercial leader in the launch planning and life cycle management for the companies first orphan drug launch for the treatment of Duchenne Muscular Dystrophy. • Successfully led negotiations for two commercial partnership agreements, including a drug-device. • Identified and resolved manufacturing issues with an international manufacturer. Show less

    • Germany
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Vice President and General Manager, West Zone
      • Jan 2012 - Sep 2013

      Vice President, West Zone 2012 – 2013 Turned around an underperforming ~1,000 member commercial team with 13 director-level direct reports: sales teams--specialty, hospital and PCP; MHC, marketing, analytics and training. • Responsible for $2 billion in annual top-line sales revenue.• Within 6 months, the Zone had a measurable inflection point in performance and in <18 months, the Zone achieved #1 YTD growth and #1 percent goal accomplishment for three launch brands and total book of business nationally (TAs included: COPD, asthma, diabetes, stroke). • Led the nation in market share growth for the launch of two oral diabetes products (DPP-4).• Established strong alliances and partnership with MHC team. Developed a MHC account-level performance and contract dash board resulting in lock-step field communication, strategic planning, goal setting and execution which contributed to nation leading sales results. Show less

    • Executive Director of Hospital Specialty Sales
      • Apr 2010 - Dec 2011

      Built/hired/designed the hospital sales team in preparation for the launch of PRADAXA (recruited by CEO). Presented strategic launch plan -- sales force structure & size and hospital brand strategy to the Senior Steering Committee 3 weeks after hiring. Hired a world-class hospital sales team in 8 weeks, developed an account management training plan and trained the new 210 member hospital team in < 6 months.• Exceeded PRADAXA hospital formulary acceptance and sales forecasts for 2010 and 2011.• Gained hospital formulary access in over 1,300 hospital (80% of targets) within 6 months. Show less

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Hospital Sales Director
      • May 2003 - Apr 2010

      Led a 63-person field based team. Responsibilities included management of district managers, region account directors, and region trainer, launching and selling IV antibiotics, pain products and medical devices in academic medical centers and in integrated delivery networks. • Created a new national level IDN account management team structure and account management platform. Shifted focus from a product centric to a customer centric approach. Led a cross-functional team in the national roll-out of the project. Received a Johnson & Johnson Global Standards of Leadership Award and bonus for my leadership and initiative. • Integrated a new sales management team based on an organizational re-alignment and turned around three of the lowest performing teams into national sales growth leaders in less than one year. • Led the nation in units sold for the launch of Bio Patch (drug-device combination) Led a 69-person sales team selling antipsychotics, Alzheimer’s & pain products in the hospital setting. • Led the nation in launch of both Risperdal Consta and Reminyl. Gained national VHA formulary status for both agents in record time. • President’s Circle winner (#1 national ranking) in first year with Janssen Pharmaceutica (2003). • President’s Circle: #1 national ranking at time of integration with Ortho-McNeil (November, 2004). Show less

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • National Sales Director, Immunology (HUMIRA)
      • Dec 2001 - May 2003

      Built/hired the sales force to launch HUMIRA and was a member of the global senior leadership launch team integral in the development of the pre-launch planning and launch strategy for HUMIRA, Abbott’s blockbuster TNF biologic with annual global sales exceeding $13 billion. • Developed and executed the US sales force launch plan including the size, structure, training, incentive compensation and hiring of the US Immunology sales force. • Led Gengraf commercial team and co-promotion partnership with P/L responsibility for the transplant specialty sales force. Increased year-over-year sales 47%. Show less

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • National Sales Director, Built New PCP Sales Team
      • 1999 - 2001

      Built/hired a new 350 member sales force from the ground up and lead marketing team to launch OMNICEF. • Achieved “speed to impact” goal by hiring 3 region sales directors, 18 district sales managers and 250 representatives within 4 weeks. Organization was hired, trained and deployed within 8 weeks.• Created a dynamic, confident team culture of highly skilled, focused and disciplined managers and representatives who were recognized by divisional President as the model team to emulate. • Increased sales 63% in year one and 110% in year two and expanded sales force to 350 members. • Significantly exceeded long-range forecast by achieving peak annual sales > $700MM in 2006.• Marketing team had dotted line reporting structure to this position.• Conducted quarterly business reviews with international partner. Show less

    • National Sales Director, Hospital Sales Force
      • 1998 - 1999

      Turned around an underperforming 280 member hospital sales force (including a contract sales organization) with consistently high turnover of 46%. • New national level structure was created for me to lead and turn-around the hospital sales team.• Quickly diagnosed organizational issues, gained alignment with the leadership team and established the hospital sales force as a top Abbott sales team in less than 1 year.• Achieved “turn around” objective in first year by driving increased performance, significantly reduced turnover (<5%) and created a dynamic organizational culture. Show less

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Region Sales Director
      • Aug 1996 - Dec 1998

      Led a 130-person sales team comprised of specialty, hospital and primary care representatives and managers.• Changed the culture from a problem-centric to a solution-oriented mind-set resulting in the region increasing its national ranking for every promoted product including making BIAXIN OS #1 nationally.• Led the nation in TRx volume and market share for the launch of a leukotriene inhibitor (asthma)

    • Senior Marketing Manager
      • Jul 1993 - Aug 1996

      Hired a marketing team, developed launch plan and successfully launched DEPAKOTE for BIPOLAR DISORDER.• Significantly exceeded sales, Rx and market share forecasts in consecutive years by establishing exceptional relationships with KOLs, creating a clear and impactful brand positioning, messaging communicated a clear and meaningful value proposition, formed a strong sales force partnership. • Created/shaped the bipolar market as the first new bipolar approval in 25 years since lithium.• Developed long-range life-cycle management plan and clinical development plan. Show less

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • National Manager, Antimicrobial Medical Science Liaisons
      • 1992 - 1993

      Led an 11-person team of MSLs developing new markets and indications for anti-infective and HIV compounds.• Optimized approach to investigator initiated clinical trials resulting in higher quality studies, increased speed of completion, improved customer relationships, reduced cost and enhanced impact & efficiency and team morale and motivation. Published over 500 peer-reviewed papers, posters and abstracts.

    • Marketing Manager, Antimicrobial Business Unit
      • 1990 - 1992

      Launched BIAXIN as a Global senior launch team member from pre-launch through to launch and post-launch.• Exceeded forecast and Wall Street expectations by creating a clear, simple and compelling positioning, simple, yet impactful message and comprehensive launch plan. Annual sales exceeded $1.5 billion.• Led a cross functional multi-company team including R&D, developed clinical development plan (phase III clinical trials) and successfully achieved new indication and commercial launch for H. pylori. Show less

Education

  • Northern Michigan University
    BS, Biochemistry
    1980 - 1984

Community

You need to have a working account to view this content. Click here to join now